| Clinical data | |
|---|---|
| Other names | DL-588 |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C14H16N2 |
| Molar mass | 212.296 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Napactadine (DL-588) is anantidepressant which has structural properties that look similar toPAL-287 ormethamnetamine, but is based on anamidine functional group.[1]
The synthesis of napactadine has been described:[2][3]

Reaction of N-methyl-2-(naphthalen-2-yl)acetamide [2086-65-9] (1) withtriethyloxonium fluoroborate (Meerwein reagent) [368-39-8] (2) affords the correspondingimino ether (3). Exposure of this intermediate tomethylamine (4) leads to napactidine (5).
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |